Successful paediatric HIV treatment in rural primary care in Africa

Archives of Disease in Childhood

Volumn 95, Issue 6, 2010, Pages 414-421

  Janssen, N ^a   Ndirangu, J ^a   Newell, M L ^a,b   Bland, Ruth M ^a,c  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; EFAVIRENZ; HEMOGLOBIN; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; STAVUDINE;

ARTICLE; CD4 LYMPHOCYTE COUNT; CHILD; CHILD DEATH; CHILDHOOD MORTALITY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RURAL AREA; SOUTH AFRICA; SURVIVAL; TREATMENT OUTCOME; TUBERCULOSIS; VIRUS LOAD;

ADOLESCENT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; EPIDEMIOLOGIC METHODS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; MALE; PRIMARY HEALTH CARE; PROGRAM EVALUATION; RURAL HEALTH SERVICES; SOUTH AFRICA; TREATMENT OUTCOME; VIRAL LOAD;

EID: 77953710656     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2009.169367     Document Type: Article

References (39)

1. Gibb DM, Duong T, Tookey PA, et al. Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and Ireland. BMJ 2003;327:1019.
2. Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, et al. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. JAMA 2007;298:1888-99.
3. Fassinou P, Elenga N, Rouet F, et al. Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Côte d'Ivoire. AIDS 2004;18:1905-13.
4. O'Brien DP, Sauvageot D, Zachariah R, et al. In resource-limited settings good early outcomes can be achieved in children using adult fi xed-dose combination antiretroviral therapy. AIDS 2006;20:1955-60.
5. Puthanakit T, Oberdorfer A, Akarathum N, et al. Effi cacy of highly active antiretroviral therapy in HIV-infected children participating in Thailand's National Access to Antiretroviral Program. Clin Infect Dis 2005;41:100-7.
6. Jones SA, Sherman GG, Varga CA. Exploring socio-economic conditions and poor follow-up rates of HIV-exposed infants in Johannesburg, South Africa. AIDS Care 2005;17:466-70.
7. UNAIDS UNICEF and WHO. Children and AIDS. A stocktaking report. 2007.
8. Violari A, Cotton MF, Gibb DM, et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med 2008;359:2233-44.
9. Newell ML, Patel D, Goetghebuer T, et al. CD4 cell response to antiretroviral therapy in children with vertically acquired HIV infection: is it associated with age at initiation? J Infect Dis 2006;193:954-62.
10. Rollins N, Little K, Mzolo S, et al. Surveillance of mother-to-child transmission prevention programmes at immunization clinics: the case for universal screening. AIDS 2007;21:1341-7.
11. Braitstein P, Brinkhof MW, Dabis F, et al. Mortality of HIV-1-infected patients in the fi rst year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 2006;367:817-24.
12. Medecins Sans Frontieres. Too many children with HIV/AIDS still waiting. http://www.msfaccess.org/main/hiv-aids/introduction-to-hivaids/ children-andhivaids/ (accessed 17 March 2010).
13. Welz T, Hosegood V, Jaffar S, et al. Continued very high prevalence of HIV infection in rural KwaZulu-Natal, South Africa: a population-based longitudinal study. AIDS 2007;21:1467-72.
14. WHO. Antiretroviral therapy of HIV infection in infants and children in resource limited settings: Towards universal accses 2006 [cited 2006 July]; available from: https://www.who.int/entity/hiv/pub/guidelines/art/en/index.html. 2006.
15. The KIDS-ART-LINC Collaboration. Low risk of death, but substantial program attrition, in pediatric HIV treatment cohorts in Sub-Saharan Africa. J Acquir Immune Defi c Syndr 2008;49:523-31.
16. Rice BD, Bätzing-Feigenbaum J, Hosegood V, et al. Population and antenatalbased HIV prevalence estimates in a high contracepting female population in rural South Africa. BMC Public Health 2007;7:160.
17. Solarsh G, Benzler J, Hosegood V, et al. Hlabisa DSS, South Africa. In Network I, (ed.). Population and Health in Developing Countries. Population, Health and Survival at INDEPTH sites. Ottawa: International Development Research Centre, 2002:213-20.
18. Wilkinson D, Cutts F, Ntuli N, et al. Maternal and child health indicators in a rural South African health district. S Afr Med J 1997;87:456-9.
19. Ndirangu J, Barnighausen T, Tanser F, et al. Is maternal HIV status associated with childhood vaccination status? Data from rural KwaZulu-Natal. 4th SA AIDS Conference, ICC, Durban, 31st March - 3rd April, 2009.
20. Tanser F, Hosegood V, Benzler J, et al. New approaches to spatially analyse primary health care usage patterns in rural South Africa. Trop Med Int Health 2001;6:826-38.
21. Meyers T, Moultrie H, Naidoo K, et al. Challenges to pediatric HIV care and treatment in South Africa. J Infect Dis 2007;196 Suppl 3:S474-81. (Pubitemid 351417241)
22. Coovadia H, Bland R. From Alma-Ata to Agincourt: primary health care in AIDS. Lancet 2008;372:866-8.
23. Step-by-Step Guide for the Management of Children on ART, 2nd ed. March 2004. Department of Paediatrics, Pietermaritzburg Metropolitan Hospitals, KwaZulu-Natal.
24. Step-by-Step Guide for the Management of Children on ART, 3rd ed. March 2008. Department of Paediatrics, Pietermaritzburg Metropolitan Hospitals, KwaZulu-Natal.
25. Houlihan C, Mutevedzi P, Cooke G, et al. The challenge posed by tuberculosis to a rural HIV programme with a high prevalence of both tuberculosis and HIV. Abstract 263. Southern African AIDS Conference Durban, South Africa 2009.
26. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Statist Assoc 1958;53:457-81.
27. Cox D, Oakes D. Analysis of survival data. Monographs on statistics and applied probability. Boca Raton, FL: Chapman and Hall/CRC, 1984. http://books.google.com/books?hl=en&lr=&id=Y4pdM2soP4IC&oi= fnd&pg=PR9&dq=Cox+D+ANalysis+of+survival+data&ots= hITjiEcPlr&sig=D-T9vJ4O3kHF7OD8FBGkfQB-fN0" \l "v=onepage&q= &f=false (accessed 17 March 2010).
28. CDC, Growth Charts: United States. http://www.cdc.gov/nccdphp/dnpa/ growthcharts/resources/index.htm#BMI.
29. de Onis M, Onyango AW, Borghi E, et al. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ 2007;85:660-7. (Pubitemid 47416716)
30. Zachariah R, Fitzgerald M, Massaquoi M, et al. Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi. AIDS 2006;20:2355-60. (Pubitemid 44789538)
31. Tanser F, Gijsbertsen B, Herbst K. Modelling and understanding primary health care accessibility and utilization in rural South Africa: an exploration using a geographical information system. Soc Sci Med 2006;63:691-705. (Pubitemid 43831423)
32. Fredlund VG, Nash J. How far should they walk? Increasing antiretroviral therapy access in a rural community in northern KwaZulu-Natal, South Africa. J Infect Dis 2007;196 Suppl 3:S469-73. (Pubitemid 351417240)
33. Gilks CF, Crowley S, Ekpini R, et al. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet 2006;368:505-10. (Pubitemid 44142772)
34. Kober K, Van Damme W. Scaling up access to antiretroviral treatment in southern Africa: who will do the job? Lancet 2004;364:103-7. (Pubitemid 38968632)
35. Sutcliffe CG, van Dijk JH, Bolton C, et al. Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. Lancet Infect Dis 2008;8:477-89. (Pubitemid 352005822)
36. Rouet F, Sakarovitch C, Msellati P, et al. Pediatric viral human immunodefi ciency virus type 1 RNA levels, timing of infection, and disease progression in African HIV-1-infected children. Pediatrics 2003;112:e289.
37. Manzi M, Zachariah R, Teck R, et al. High acceptability of voluntary counselling and HIV-testing but unacceptable loss to follow up in a prevention of mother-tochild HIV transmission programme in rural Malawi: scaling-up requires a different way of acting. Trop Med Int Health 2005;10:1242-50. (Pubitemid 41789677)
38. Calis JC, van Hensbroek MB, de Haan RJ, et al. HIV-associated anemia in children: a systematic review from a global perspective. AIDS 2008;22:1099-112.
39. Boulle A, Bock P, Osler M, et al. Antiretroviral therapy and early mortality in South Africa. Bull World Health Organ 2008;86:678-87.